Insight Molecular Diagnostics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Insight Molecular Diagnostics Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $10.00K.
- Insight Molecular Diagnostics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $11.00K, a 99.19% decline year-over-year.
- Insight Molecular Diagnostics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $974.00K, a 1252.78% increase year-over-year.
- Insight Molecular Diagnostics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $1.25M.
- Insight Molecular Diagnostics Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $2.58M, a 81.72% increase from fiscal 2020.
- Insight Molecular Diagnostics Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $1.42M, a 50.80% increase from fiscal 2019.
- Insight Molecular Diagnostics Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $943.00K, a 1525.86% increase from fiscal 2018.
- Insight Molecular Diagnostics Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $58.00K, a 90.49% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $10.00K 10-Q · filed 2026-08-10 | |
| 2021-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $2.58M 10-K · filed 2023-04-12 |
| 2021-09-30 | $974.00K 10-Q · filed 2022-11-10 | $3.92M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.25M 10-Q · filed 2022-08-12 | $3.02M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $348.00K 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.42M 10-K · filed 2022-03-11 |
| 2020-09-30 | $72.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $943.00K 10-K · filed 2021-03-19 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $942.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $944.00K derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $943.00K 10-Q · filed 2020-05-12 | $949.00K derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $58.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $2.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $5.00K 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $51.00K 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $610.00K 10-K · filed 2019-04-01 | |
| 2016-12-31 | $218.00K 10-K · filed 2018-04-02 | |
| 2015-12-31 | $4.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |